{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:21:08Z","timestamp":1780370468609,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Beh\u00e7et\u2019s disease (BD) is a systemic inflammatory disease that involves various organs. The clinical manifestation-based diagnosis of BD is a time-consuming process, which makes it difficult to distinguish from patients with similar symptoms. Moreover, an authentic biomarker has not been developed for accurate diagnosis yet. Our current study investigated the unique metabolic signatures of BD and explored biomarkers for precise diagnosis based on an untargeted metabolomic approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Integrative metabolomic and lipidomic profiling was performed on plasma samples of BD patients (<jats:italic>n<\/jats:italic> = 40), healthy controls (HCs, <jats:italic>n<\/jats:italic> = 18), and disease controls (DCs, <jats:italic>n<\/jats:italic> = 17) using GC-TOF MS and LC-Orbitrap MS. Additionally, the lipid profiles of 66 peripheral blood mononuclear cells (PBMCs) were analyzed from 29 BD patients, 18 HCs, and 19 DCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma metabolic dysfunction in BD was determined in carbohydrate, hydroxy fatty acid, and polyunsaturated fatty acid metabolisms. A plasma biomarker panel with 13 compounds was constructed, which simultaneously distinguished BD from HC and DC (AUCs ranged from 0.810 to 0.966). Dysregulated PBMC metabolome was signatured by a significant elevation in lysophosphatidylcholines (LPCs) and ether-linked lysophosphatidylethanolamines (EtherLPEs). Ten PBMC-derived lipid composites showed good discrimination power (AUCs ranged from 0.900 to 0.973). Correlation analysis revealed a potential association between disease activity and the metabolites of plasma and PBMC, including sphingosine-1 phosphate and EtherLPE 18:2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We identified metabolic biomarkers from plasma PBMC, which selectively discriminated BD from healthy control and patients with similar symptoms (recurrent mouth ulcers with\/without genital ulcers). The strong correlation was determined between the BD activity and the lipid molecules. These findings may lead to the development for diagnostic and prognostic biomarkers based on a better understanding of the BD pathomechanism.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02986-5","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T04:26:39Z","timestamp":1673065599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Soo Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-So","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Yup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"key":"2986_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et\u2019s disease. N Engl J Med. 1999;341:1284\u201391. https:\/\/doi.org\/10.1056\/NEJM199910213411707.","journal-title":"N Engl J Med."},{"key":"2986_CR2","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"1656","unstructured":"Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Beh\u00e7et disease. Hosp Prot. 1656;67:1656\u201362. https:\/\/doi.org\/10.1136\/ard.2007.080432.","journal-title":"Hosp Prot"},{"key":"2986_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/J.AUTREV.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, et al. Beh\u00e7et\u2019s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17:567\u201375. https:\/\/doi.org\/10.1016\/J.AUTREV.2017.12.006.","journal-title":"Autoimmun Rev."},{"key":"2986_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/J.JAUT.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Beh\u00e7et\u2019s disease: a comprehensive review. J Autoimmun. 2015;64:137\u201348. https:\/\/doi.org\/10.1016\/J.JAUT.2015.08.013.","journal-title":"J Autoimmun."},{"key":"2986_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli H. Autoimmunity vs autoinflammation in Behcet\u2019s disease: do we oversimplify a complex disorder? Rheumatology. 2006;45:1461\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kel329.","journal-title":"Rheumatology."},{"key":"2986_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/AR4328\/TABLES\/4","volume":"15","author":"MA Montes-Cano","year":"2013","unstructured":"Montes-Cano MA, Conde-Jald\u00f3n M, Garc\u00eda-Lozano JR, Ortiz-Fern\u00e1ndez L, Ortego-Centeno N, Castillo-Palma MJ, et al. HLA and non-HLA genes in Beh\u00e7et\u2019s disease: a multicentric study in the Spanish population. Arthritis Res Ther. 2013;15:1\u20139. https:\/\/doi.org\/10.1186\/AR4328\/TABLES\/4.","journal-title":"Arthritis Res Ther."},{"key":"2986_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/J.SURVOPHTHAL.2005.04.009","volume":"50","author":"C Evereklioglu","year":"2005","unstructured":"Evereklioglu C. Current concepts in the etiology and treatment of Beh\u00e7et disease. Surv Ophthalmol. 2005;50:297\u2013350. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2005.04.009.","journal-title":"Surv Ophthalmol."},{"key":"2986_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00301-1","volume":"7","author":"Y Yazici","year":"2021","unstructured":"Yazici Y, Hatemi G, Bodaghi B, Cheon JH, Suzuki N, Ambrose N, et al. Beh\u00e7et syndrome. Nat Rev Dis Prim. 2021;7:1\u201314. https:\/\/doi.org\/10.1038\/s41572-021-00301-1.","journal-title":"Nat Rev Dis Prim."},{"key":"2986_CR9","doi-asserted-by":"publisher","unstructured":"Gul FC, Nazik H, Cicek D, Demir B. Activity criteria in Beh\u00e7et\u2019s disease. Behcet\u2019s Dis. 2017:97\u2013109. https:\/\/doi.org\/10.5772\/68079.","DOI":"10.5772\/68079"},{"key":"2986_CR10","doi-asserted-by":"publisher","first-page":"587393","DOI":"10.3389\/FIMMU.2021.587393","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Su G, Huang X, Chang R, Chen Z, Ye Z, et al. Metabolomic analysis of aqueous humor identifies aberrant amino acid and fatty acid metabolism in Vogt-Koyanagi-Harada and Behcet\u2019s disease. Front Immunol. 2021;12:587393. https:\/\/doi.org\/10.3389\/FIMMU.2021.587393.","journal-title":"Front Immunol."},{"key":"2986_CR11","doi-asserted-by":"publisher","first-page":"107812","DOI":"10.1016\/J.INTIMP.2021.107812","volume":"97","author":"X Cui","year":"2021","unstructured":"Cui X, Zhang L, Su G, Kijlstra A, Yang P. Specific sweat metabolite profile in ocular Behcet\u2019s disease. Int Immunopharmacol. 2021;97:107812. https:\/\/doi.org\/10.1016\/J.INTIMP.2021.107812.","journal-title":"Int Immunopharmacol."},{"key":"2986_CR12","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/J.JTAUTO.2020.100056","volume":"3","author":"A Mendes-Frias","year":"2020","unstructured":"Mendes-Frias A, Santos-Lima B, Furtado DZS, Ruperez FJ, Assun\u00e7\u00e3o NA, Matias MJ, et al. Dysregulation of glycerophospholipid metabolism during Beh\u00e7et\u2019s disease contributes to a pro-inflammatory phenotype of circulating monocytes. J Transl Autoimmun. 2020;3:100056. https:\/\/doi.org\/10.1016\/J.JTAUTO.2020.100056.","journal-title":"J Transl Autoimmun."},{"key":"2986_CR13","first-page":"500","volume":"38","author":"JK Ahn","year":"2020","unstructured":"Ahn JK, Kim J, Cheong YE, Kim KH, Cha HS. Variation in the synovial fluid metabolome according to disease activity of rheumatoid arthritis. Clin Exp Rheumatol. 2020;38:500\u20137.","journal-title":"Clin Exp Rheumatol."},{"key":"2986_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-018-1712-Y\/TABLES\/3","volume":"20","author":"W Zheng","year":"2018","unstructured":"Zheng W, Wu X, Goudarzi M, Shi J, Song W, Li C, et al. Metabolomic alterations associated with Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2018;20:1\u201310. https:\/\/doi.org\/10.1186\/S13075-018-1712-Y\/TABLES\/3.","journal-title":"Arthritis Res Ther."},{"key":"2986_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/J.JBSPIN.2017.05.019","volume":"85","author":"JK Ahn","year":"2018","unstructured":"Ahn JK, Kim J, Hwang J, Song J, Kim KH, Cha HS. Potential metabolomic biomarkers for reliable diagnosis of Behcet\u2019s disease using gas chromatography\/ time-of-flight-mass spectrometry. Jt Bone Spine. 2018;85:337\u201343. https:\/\/doi.org\/10.1016\/J.JBSPIN.2017.05.019.","journal-title":"Jt Bone Spine."},{"key":"2986_CR16","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3390\/IJMS18112309","volume":"18","author":"JK Ahn","year":"2017","unstructured":"Ahn JK, Kim J, Hwang J, Song J, Kim KH, Cha HS. Urinary metabolomic profiling to identify potential biomarkers for the diagnosis of Behcet\u2019s disease by gas chromatography\/time-of-flight\u2212mass spectrometry. Int J Mol Sci. 2017;18:2309. https:\/\/doi.org\/10.3390\/IJMS18112309.","journal-title":"Int J Mol Sci."},{"key":"2986_CR17","doi-asserted-by":"publisher","first-page":"e0135856","DOI":"10.1371\/JOURNAL.PONE.0135856","volume":"10","author":"JK Ahn","year":"2015","unstructured":"Ahn JK, Kim S, Kim J, Hwang J, Kim KH, Cha HS. A comparative metabolomic evaluation of Behcet\u2019s disease with arthritis and seronegative arthritis using synovial fluid. PLoS One. 2015;10:e0135856. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0135856.","journal-title":"PLoS One."},{"key":"2986_CR18","doi-asserted-by":"publisher","unstructured":"International Study Group for Beh\u00e7et\u2019s disease. Criteria for diagnosis of Behcet\u2019s disease. Lancet. 1990:335. https:\/\/doi.org\/10.1016\/0140-6736(90)92643-V.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"2986_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/S10238-004-0033-4","volume":"4","author":"MS Kurokawa","year":"2004","unstructured":"Kurokawa MS, Suzuki N. Behcet\u2019s disease. Clin Exp Med. 2004;4:10\u201320. https:\/\/doi.org\/10.1007\/S10238-004-0033-4.","journal-title":"Clin Exp Med."},{"key":"2986_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41598-018-37572-w","volume":"9","author":"SJ Park","year":"2019","unstructured":"Park SJ, Kim JK, Kim HH, Yoon BA, Ji DY, Lee CW, et al. Integrative metabolomics reveals unique metabolic traits in Guillain-Barr\u00e9 syndrome and its variants. Sci Rep. 2019;9:1077. https:\/\/doi.org\/10.1038\/s41598-018-37572-w.","journal-title":"Sci Rep."},{"key":"2986_CR21","doi-asserted-by":"publisher","first-page":"e0166277","DOI":"10.1371\/journal.pone.0166277","volume":"11","author":"SJ Park","year":"2016","unstructured":"Park SJ, Jeong IH, Kong BS, Lee JE, Kim KH, Lee DY, et al. Disease type- and status-specific alteration of CSF metabolome coordinated with clinical parameters in inflammatory demyelinating diseases of CNS. PLoS One. 2016;11:e0166277. https:\/\/doi.org\/10.1371\/journal.pone.0166277.","journal-title":"PLoS One."},{"key":"2986_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jchromb.2019.03.027","volume":"1114\u20131115","author":"CW Lee","year":"2019","unstructured":"Lee CW, Lee D, Lee EM, Park SJ, Ji DY, Lee DY, et al. Lipidomic profiles disturbed by the internet gaming disorder in young Korean males. J Chromatogr B Anal Technol Biomed Life Sci. 2019;1114\u20131115:119\u201324. https:\/\/doi.org\/10.1016\/j.jchromb.2019.03.027.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"2986_CR23","doi-asserted-by":"publisher","unstructured":"Ji DY, Lee CW, Park SH, Lee EJ, Lee DY. Simple and robust measurement of blood plasma lysophospholipids using liquid chromatography mass spectrometry. Mass Spectrom Lett. 2017:8. https:\/\/doi.org\/10.5478\/MSL.2017.8.4.109.","DOI":"10.5478\/MSL.2017.8.4.109"},{"key":"2986_CR24","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1038\/s41598-017-15231-w","volume":"7","author":"DK Barupal","year":"2017","unstructured":"Barupal DK, Fiehn O. Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets. Sci Rep. 2017;7:14567. https:\/\/doi.org\/10.1038\/s41598-017-15231-w.","journal-title":"Sci Rep."},{"key":"2986_CR25","doi-asserted-by":"publisher","first-page":"827815","DOI":"10.1155\/2012\/827815","volume":"2012","author":"O Ozhan","year":"2012","unstructured":"Ozhan O, Sezer K. Behcet\u2019s disease and endocrine system. Patholog Res Int. 2012;2012:827815. https:\/\/doi.org\/10.1155\/2012\/827815.","journal-title":"Patholog Res Int."},{"key":"2986_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.14740\/JH230E","volume":"4","author":"GS Pancar","year":"2015","unstructured":"Pancar GS, Kalkan G. Diagnostic value of HbA1c level in Behcet\u2019s disease and evaluation of neutrophil-lymphocyte ratio, mean platelet volume and body mass index. J Hematol. 2015;4:219\u201322. https:\/\/doi.org\/10.14740\/JH230E.","journal-title":"J Hematol."},{"key":"2986_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/J.1468-3083.2006.01457.X","volume":"20","author":"H Erdem","year":"2006","unstructured":"Erdem H, Dinc A, Pay S, Simsek I, Turan M. Peripheral insulin resistance in patients with Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol. 2006;20:391\u20135. https:\/\/doi.org\/10.1111\/J.1468-3083.2006.01457.X.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"2986_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/DIAB.38.5.641","volume":"38","author":"VA Koivisto","year":"1989","unstructured":"Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes. 1989;38:641\u20137. https:\/\/doi.org\/10.2337\/DIAB.38.5.641.","journal-title":"Diabetes."},{"key":"2986_CR29","doi-asserted-by":"publisher","first-page":"1419352","DOI":"10.1155\/2018\/1419352","volume":"2018","author":"A Santarsiero","year":"2018","unstructured":"Santarsiero A, Leccese P, Convertini P, Padula A, Abriola P, D\u2019Angelo S, et al. New insights into Beh\u00e7et\u2019s syndrome metabolic reprogramming: citrate pathway dysregulation. Mediators Inflamm. 2018;2018:1419352. https:\/\/doi.org\/10.1155\/2018\/1419352.","journal-title":"Mediators Inflamm."},{"key":"2986_CR30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/J.LFS.2005.07.038","volume":"78","author":"MF Cury-Boaventura","year":"2006","unstructured":"Cury-Boaventura MF, Gorj\u00e3o R, De Lima TM, Newsholme P, Curi R. Comparative toxicity of oleic and linoleic acid on human lymphocytes. Life Sci. 2006;78:1448\u201356. https:\/\/doi.org\/10.1016\/J.LFS.2005.07.038.","journal-title":"Life Sci."},{"key":"2986_CR31","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1096\/fj.201601248R","volume":"31","author":"JM Houthuijzen","year":"2017","unstructured":"Houthuijzen JM, Oosterom I, Hudson BD, Hirasawa A, Daenen LGM, McLean CM, et al. Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance. FASEB J. 2017;31:2195\u2013209. https:\/\/doi.org\/10.1096\/fj.201601248R.","journal-title":"FASEB J."},{"key":"2986_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/J.MOLMED.2008.08.005","volume":"14","author":"H Harizi","year":"2008","unstructured":"Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008;14:461\u20139. https:\/\/doi.org\/10.1016\/J.MOLMED.2008.08.005.","journal-title":"Trends Mol Med."},{"key":"2986_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fimmu.2013.00130","volume":"4","author":"AM Lone","year":"2013","unstructured":"Lone AM, Task\u00e9n K. Proinflammatory and immunoregulatory roles of eicosanoids in T cells. Front. Immunol. 2013;4:130. https:\/\/doi.org\/10.3389\/fimmu.2013.00130.","journal-title":"Front. Immunol."},{"key":"2986_CR34","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","volume":"76","author":"HC Tsai","year":"2016","unstructured":"Tsai HC, Han MH. Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation. Drugs. 2016;76:1067\u201379. https:\/\/doi.org\/10.1007\/s40265-016-0603-2.","journal-title":"Drugs."},{"key":"2986_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s40265-021-01528-8","volume":"81","author":"T P\u00e9rez-Jeldres","year":"2021","unstructured":"P\u00e9rez-Jeldres T, Alvarez-Lobos M, Rivera-Nieves J. Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis. Drugs. 2021;81:985\u20131002. https:\/\/doi.org\/10.1007\/s40265-021-01528-8.","journal-title":"Drugs."},{"key":"2986_CR36","doi-asserted-by":"publisher","unstructured":"Snyder F. Chapter 7 Ether-linked lipids and their bioactive species: occurrence, chemistry, metabolism, regulation, and function. New Compr Biochem. 1996;Chapter 7:183-210. https:\/\/doi.org\/10.1016\/S0167-7306(08)60514-1.","DOI":"10.1016\/S0167-7306(08)60514-1"},{"key":"2986_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fmolb.2017.00096","volume":"4","author":"P Sen","year":"2018","unstructured":"Sen P, Kemppainen E, Ore\u0161i\u010d M. Perspectives on systems modeling of human peripheral blood mononuclear cells. Front. Mol. Biosci. 2018;4:96. https:\/\/doi.org\/10.3389\/fmolb.2017.00096.","journal-title":"Front. Mol. Biosci."},{"key":"2986_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12950-016-0130-7","volume":"13","author":"MY Woo","year":"2016","unstructured":"Woo MY, Yun SJ, Cho O, Kim K, Lee ES, Park S. MicroRNAs differentially expressed in Beh\u00e7et disease are involved in interleukin-6 production. J Inflamm. 2016;13:22. https:\/\/doi.org\/10.1186\/s12950-016-0130-7.","journal-title":"J Inflamm."},{"key":"2986_CR39","first-page":"S9","volume":"32","author":"T Yoshioka","year":"2014","unstructured":"Yoshioka T, Kurokawa MS, Sato T, Nagai K, Iizuka N, Arito M, et al. Protein profiles of peripheral blood mononuclear cells as a candidate biomarker for Beh\u00e7et\u2019s disease. Clin Exp Rheumatol. 2014;32:S9\u201319.","journal-title":"Clin Exp Rheumatol."},{"key":"2986_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0005-2760(90)90520-8","volume":"1047","author":"T Sugiura","year":"1990","unstructured":"Sugiura T, Fukuda T, Masuzawa Y, Waku K. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes. Biochim Biophys Acta. 1990;1047:223\u201332. https:\/\/doi.org\/10.1016\/0005-2760(90)90520-8.","journal-title":"Biochim Biophys Acta."},{"key":"2986_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.1365-2249.1999.00871.x","volume":"116","author":"YH Huang","year":"1999","unstructured":"Huang YH, Sch\u00e4fer-Elinder L, Wu R, Claesson HE, Frosteg\u00e5rd J. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol. 1999;116:326\u201331. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00871.x.","journal-title":"Clin Exp Immunol."},{"key":"2986_CR42","doi-asserted-by":"publisher","first-page":"e0227836","DOI":"10.1371\/journal.pone.0227836","volume":"15","author":"MA Islam","year":"2020","unstructured":"Islam MA, Alam SS, Kundu S, Safayet Ullah Prodhan AHM, Khandker SS, Reshetnyak T, et al. Prevalence of antiphospholipid antibodies in Beh\u00e7et\u2019s disease: a systematic review and meta-analysis. PLoS One. 2020;15:e0227836. https:\/\/doi.org\/10.1371\/journal.pone.0227836.","journal-title":"PLoS One."},{"key":"2986_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jid.2019.03.1133","volume":"140","author":"AK Brys","year":"2020","unstructured":"Brys AK, Rodriguez-Homs LG, Suwanpradid J, Atwater AR, MacLeod AS. Shifting paradigms in allergic contact dermatitis: the role of innate immunity. J. Invest. Dermatol. 2020;140:21\u20138. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1133.","journal-title":"J. Invest. Dermatol."},{"key":"2986_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.aca.2018.04.036","volume":"1026","author":"Y Xu","year":"2018","unstructured":"Xu Y, Zhang M, Wang Q, Li Z. In situ detecting changes in membrane lipid phenotypes of macrophages cultured in different cancer microenvironments using mass spectrometry. Anal Chim Acta. 2018;1026:101\u20138. https:\/\/doi.org\/10.1016\/j.aca.2018.04.036.","journal-title":"Anal Chim Acta."},{"key":"2986_CR45","doi-asserted-by":"publisher","first-page":"e6261","DOI":"10.1371\/journal.pone.0006261","volume":"4","author":"J Graessler","year":"2009","unstructured":"Graessler J, Schwudke D, Schwarz PEH, Herzog R, Schevchenko A, Bornstein SR. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One. 2009;4:e6261. https:\/\/doi.org\/10.1371\/journal.pone.0006261.","journal-title":"PLoS One."},{"key":"2986_CR46","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/ars.2009.2597","volume":"12","author":"VN Bochkov","year":"2010","unstructured":"Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, St\u00f6ckl J. Generation and biological activities of oxidized phospholipids. Antioxidants Redox Signal. 2010;12:1009\u201359. https:\/\/doi.org\/10.1089\/ars.2009.2597.","journal-title":"Antioxidants Redox Signal."},{"key":"2986_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2217\/ijr.13.40","volume":"8","author":"AJ Snider","year":"2013","unstructured":"Snider AJ. Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease. Int. J. Clin. Rheumtol. 2013;8:4. https:\/\/doi.org\/10.2217\/ijr.13.40.","journal-title":"Int. J. Clin. Rheumtol."},{"key":"2986_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1084\/jem.20091619","volume":"207","author":"THM Pham","year":"2010","unstructured":"Pham THM, Baluk P, Xu Y, Grigorova I, Bankovich AJ, Pappu R, et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med. 2010;207:17\u201327. https:\/\/doi.org\/10.1084\/jem.20091619.","journal-title":"J Exp Med."},{"key":"2986_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1758-5996-5-24","volume":"5","author":"EL Donovan","year":"2013","unstructured":"Donovan EL, Pettine SM, Hickey MS, Hamilton KL, Miller BF. Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean. Diabetol Metab Syndr. 2013;5:24. https:\/\/doi.org\/10.1186\/1758-5996-5-24.","journal-title":"Diabetol Metab Syndr."},{"key":"2986_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2017.06.006","volume":"189","author":"DJ Stephenson","year":"2017","unstructured":"Stephenson DJ, Hoeferlin LA, Chalfant CE. Lipidomics in translational research and the clinical significance of lipid-based biomarkers. Transl. Res. 2017;189:13\u201329. https:\/\/doi.org\/10.1016\/j.trsl.2017.06.006.","journal-title":"Transl. Res."},{"key":"2986_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/can.2016.0002","volume":"1","author":"V Chiurchi\u00f9","year":"2016","unstructured":"Chiurchi\u00f9 V. Endocannabinoids and immunity. Cannabis Cannabinoid Res. 2016;1:59\u201366. https:\/\/doi.org\/10.1089\/can.2016.0002.","journal-title":"Cannabis Cannabinoid Res"},{"key":"2986_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0006-2952(02)01179-6","volume":"64","author":"JHS Kabarowski","year":"2002","unstructured":"Kabarowski JHS, Xu Y, Witte ON. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 2002;64:161\u20137. https:\/\/doi.org\/10.1016\/S0006-2952(02)01179-6.","journal-title":"Biochem. Pharmacol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02986-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:59:06Z","timestamp":1673366346000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02986-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2986"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02986-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Ajou University Hospital (IRB number: AJIRB-BMR-GEN-14-463). Informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}